[Clinical observations on the combination citrogenase-aminoxidase-tyrosine (Vasolastine)].
D000328:Adult; D000368:Aged; D000594:Amino Acid Oxidoreductases / Q000008:administration & dosage; D001161:Arteriosclerosis / Q000188:drug therapy*; D004156:Catechol Oxidase / Q000008:administration & dosage*; D003327:Coronary Disease / Q000188:drug therapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007273:Injections, Intramuscular; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008190:Lyases / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010088:Oxidoreductases / Q000008:administration & dosage*
D010088:Oxidoreductases; D004156:Catechol Oxidase; D000594:Amino Acid Oxidoreductases; D008190:Lyases
Observacões clínicas sôbre o complexo citrogenase-aminoxidase-tirosinase (Vasolastine)